India, Sept. 11 -- Senores Pharmaceuticals Ltd announced that the US Food and Drug Administration (USFDA) has successfully completed an inspection of the manufacturing facility of its subsidiary, Apnar Pharma Pvt Ltd, in Vadodara, Gujarat.
The inspection was conducted from September 7 to September 11, 2026, and concluded with one minor procedural observation and no GMP-related observations, according to the company's regulatory filing.
Apnar Pharma will submit its response to the USFDA within the stipulated timeframe.
Published by HT Digital Content Services with permission from Dion Global Solutions Limited....